CMS Lifesciences update - Autumn 2012: New amendment to the Act on Pharmaceuticals in the Czech Republic to limit parallel exports?
15.11.2012Company: CMS
The Czech Chamber of Deputies is currently processing a draft amendment to the Act on Pharmaceuticals. Prepared by the Ministry of Health and passed by the Government at the end of August 2012, the long-awaited amendment is now being debated in the Parliament.
It addresses mainly the following three issues that have impact on the Czech health care system: re-exports of medicinal products abroad; patients’ awareness of the prices and reimbursements of medicinal products and abuse of certain medicinal products. At the same time, it implements Directive 2011/62/EU, regarding the prevention of the entry of falsifi ed medicinal products into the legal supply chain, and Directive 2010/84/EU regarding the pharmacovigilance.
You can now download the full update via the link below.
